David A. Cousins
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
The fetal exposome: cellular and epigenetic programming of neonatal immune function.
Journal: Frontiers in immunology
Published: May 31, 2026
Pharmacological augmentation for people with treatment-resistant depression.
Journal: The British journal of psychiatry : the journal of mental science
Published: May 19, 2026
Brain lithium temporospatial kinetics in bipolar disorder: a repeated-measures 7Li MRI study of dosing regimens in Germany.
Journal: The lancet. Psychiatry
Published: March 06, 2026
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.
Journal: Journal of chemical information and modeling
Published: February 26, 2026
A one-compartment model provides benchmark Lithium dose prediction.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 30, 2025
Lithium Point-of-Care Testing to Improve Adherence to Monitoring Guidelines and Quality of Maintenance Therapy: Protocol for a Randomised Feasibility Trial.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 14, 2025
A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral Discovery.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
A Survey Exploring People's Experiences With Lithium Bought as a Supplement: Une enquête sur l'expérience des personnes avec le lithium en supplément.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: March 28, 2025
Patient experiences with brain 1H proton and 7Lithium magnetic resonance imaging before and during lithium treatment for bipolar affective disorder: a qualitative analysis.
Journal: International journal of bipolar disorders
Published: March 22, 2025
Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response.
Journal: bioRxiv : the preprint server for biology
Published: September 04, 2024
Last Updated: 09/26/2026